-
-
-
-
-
-
-
GRAIL, Inc. (GRAL) Reports Q1 Loss of $2.29
-
-
-
-
-
-
-
GRAIL, Inc. (GRAL) call put ratio 1.2 calls to 1 put amid wide price movement
-
-
-
-
-
-
-
Baird Starts GRAIL, Inc. (GRAL) at Outperform
-
-
-
-
-
-
-
GRAIL, Inc. (GRAL) Tops Q3 EPS by 153c
-
-
-
-
-
-
-
GRAIL, Inc. (GRAL) PT Raised to $38 at Morgan Stanley
-
-
-
-
-
-
-
GRAIL (GRAL) and athenahealth Team Up to Offer Healthcare Providers Streamlined Ordering of GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test
-
-
-
-
-
-
-
GRAIL, Inc. (GRAL): Results of Galleri Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology
-
434,683 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

